To the Editor: We are writing in response to the perspective on Japanese encephalitis (JE) by Erlanger et al. (1). Growing awareness is encouraging, yet because JE is a largely neglected disease, information is often contradictory or not readily available. We would like to supplement the authors’ review with clarification on available vaccines and actions countries are taking to evaluate and control JE.
No takes yet. Share an insight, caveat, or question.
Hills et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: